These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


79 related items for PubMed ID: 197227

  • 1. Studies on the mechanism of stimulation of dopamine synthesis by amphetamine in striatal slices.
    Uretsky NJ, Snodgrass SR.
    J Pharmacol Exp Ther; 1977 Sep; 202(3):565-80. PubMed ID: 197227
    [No Abstract] [Full Text] [Related]

  • 2. Effect of dibutyryl cyclic adenosine monophosphate on 14C-dopamine biosynthesis in rat brain striatal slices.
    Anagnoste B, Shirron C, Friedman E, Goldstein M.
    J Pharmacol Exp Ther; 1974 Dec; 191(3):370-6. PubMed ID: 4154377
    [No Abstract] [Full Text] [Related]

  • 3. Effects of in vivo amphetamine administration on dopamine synthesis regulation in rat brain striatal synaptosomes.
    Patrick RL, Berkowitz AL, Regenstein AC.
    J Pharmacol Exp Ther; 1981 Jun; 217(3):686-91. PubMed ID: 7229999
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The effect of reserpine treatment in vivo upon L-dopa and amphetamine evoked dopamine and DOPAC efflux in vitro from the corpus striatum of male rats.
    Dluzen DE, Liu B.
    J Neural Transm Gen Sect; 1994 Jun; 95(3):209-22. PubMed ID: 7865176
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes.
    Bowyer JF, Spuhler KP, Weiner N.
    J Pharmacol Exp Ther; 1984 Jun; 229(3):671-80. PubMed ID: 6726652
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effects of amphetamine on potassium-stimulated release of [3H]dopamine from striatal slices and synaptosomes.
    Bowyer JF, Masserano JM, Weiner N.
    J Pharmacol Exp Ther; 1987 Jan; 240(1):177-86. PubMed ID: 3100768
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms involved in the control of extrapyramidal dysfunctions and in striatal dopamine synthesis.
    Goldstein M, Anagnoste B, Battista AF, Miyamoto T, Fuxe K.
    Adv Neurol; 1974 Jan; 5():79-85. PubMed ID: 4374069
    [No Abstract] [Full Text] [Related]

  • 12. Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model.
    Fischer JF, Cho AK.
    J Pharmacol Exp Ther; 1979 Feb; 208(2):203-9. PubMed ID: 762652
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum.
    Arbilla S, Langer SZ.
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):45-52. PubMed ID: 7366741
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Striatal tyrosine hydroxylase: comparison of the activation produced by depolarization and dibutyryl-cAMP.
    Simon JR, Roth RH.
    Mol Pharmacol; 1979 Jul; 16(1):224-33. PubMed ID: 39245
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Modafinil evokes striatal [(3)H]dopamine release and alters the subjective properties of stimulants.
    Dopheide MM, Morgan RE, Rodvelt KR, Schachtman TR, Miller DK.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):112-23. PubMed ID: 17477916
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.